Efficacy of a Classification Based 'Cognitive Functional Therapy' in Nurses With Non Specific Chronic Low Back Pain

January 31, 2019 updated by: Prof. dr. Wim Dankaerts, KU Leuven

Efficacy of a Classification Based 'Cognitive Functional Therapy' in Nurses With Non Specific Chronic Low Back Pain - a Series of Case-controls

A series of case-studies to explore the efficacy of classification based cognitive functional physiotherapy according to the classification system proposed by Peter O'Sullivan in specific nursing population with non specific chronic low back pain.

The investigators hypothesis was that treatment targeting the mechanisms behind the problem from a multidimensional perspective would be effective to reduce pain, disability and sick-leave.

Study Overview

Status

Completed

Detailed Description

Low back pain (LBP) is a common, recalcitrant and costly health problem, which limits patients' daily activities. In 85% of the cases, LBP is classified as 'non-specific', which means there is no clear underlying patho-anatomical/radiological abnormality. This subgroup often gives rise to a chronic fluctuating problem. Although most cases of LBP resolve within 8 to 12 weeks, it may become chronic in up to 15% of patients. LBP constitutes an enormous and growing medical and socio-economical problem for the modern society. Nursing has been identified amongst the top professions at risk for occupational LBP, with lifetime prevalence between 66%-82%. The impact of LBP for nurses includes time off work, increased risk of chronicity, associated personal and economic costs and reduced nursing workforce efficiency.

Non Specific Chronic Low Back Pain (NSCLBP) is widely viewed as a multifactorial biopsychosocial pain syndrome. It has been proposed by several authors that NSCLBP represents a vicious cycle associated with different combinations of maladaptive; cognitive (negative beliefs, fear avoidance behaviours, catastrophising, depression, stress, lack of pacing and coping), physical (pain provocative postures, movement patterns and pain behaviours) and lifestyle (inactivity, rest) behaviours that act to promote pain and disability. However a recent systematic review suggests that this change in paradigm and the investigators new understanding of NSCLBP has not resulted in clinical trials utilizing multidimensional classification systems or targeted interventions based on the underlying mechanisms. In line with this paradigm shift a novel multidimensional classification system has been developed incorporating the biopsychosocial model, which subgroups patients based on their underlying pain mechanism. Enabling a classification based interventions targetting the maladaptive cognitive, physical and lifestyle behaviours associated with the disorder.

Study Type

Interventional

Enrollment (Actual)

41

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Antwerpen
      • Lille, Antwerpen, Belgium, 2275
        • Lindelo

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

14 years to 61 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Low Back Pain (LBP) with/without referred pain in buttock/thigh for > 3 months, including the four weeks prior to testing
  • LBP is primarily localised from T12 to gluteal folds
  • mechanical provocation of LBP with postures, movement and activities
  • average pain intensity in the past week Numerical Rating Scale (NRS) >/= 1/10
  • Disability (ODI) >/=2%
  • willingness to sign the informed consent

Exclusion Criteria:

  • specific spinal pathology
  • presence of red flags
  • previous lumbar spinal surgery
  • pregnancy
  • diagnosed psychiatric disorder - somatisation
  • radicular pain with positive neural tissue provocation test
  • widespread non-specific pain disorder (no primary LBP focus)
  • specific diagnoses: active rheumatologic disease, progressive neurological disease, serious cardiac or other internal medical condition, malignant basic diseases, acute traumas, infections, or acute vascular catastrophes

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Classification Based Cognitive Functional Therapy
A novel multidimensional classification system has been developed incorporating the biopsychosocial model, which subgroups patients based on their presentation. This subclassification is the base for matched interventions directed at the maladaptive cognitive, physical and lifestyle behaviours associated with the disorder. The intervention is called 'cognitive functional therapy' as it directly challenges these behaviours in a functionally specific and graduated manner.
Other Names:
  • cognitive functional therapy

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from baseline in pain
Time Frame: 3, 6, 9 and 12 months
Pain was assessed using a numerical pain rating scale (NPRS) ranging from 0 (no pain) to 10 (worst imaginable pain)
3, 6, 9 and 12 months
Change from baseline in disability
Time Frame: 3, 6, 9 months, 1 and 3 year
Disability was measured using the Oswestry Disability Index (ODI)
3, 6, 9 months, 1 and 3 year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from baseline in Beliefs about LBP
Time Frame: 3, 6, 9 and 12 months
Back Beliefs Questionnaire (BBQ)
3, 6, 9 and 12 months
Change from baseline in Chance of long-term disability and failure to return to work
Time Frame: 3, 6, 9 and 12 months
Tha Acute Low Back Pain Screening Questionnaire (Dutch version of the Ørebro Pain Screening Questionnaire) is a 'yellow flag' screening tool that predicts long-term disability and failure to return to work due to personal and environmental factors.
3, 6, 9 and 12 months
Change from baseline in Physical activity
Time Frame: 3, 6, 9 and 12 months
Baecke questionnaire
3, 6, 9 and 12 months
Change from baseline in Sleep problems
Time Frame: 3, 6, 9 and 12 months
Insomnia Severity Index (ISI)
3, 6, 9 and 12 months
Change from baseline in Depression, anxiety and stress
Time Frame: 3, 6, 9 and 12 months
Depression Anxiety and Stress scale (DASS-21)
3, 6, 9 and 12 months
Change from baseline in Self-efficacy, coping
Time Frame: 3, 6, 9 and 12 months
Pain Self-Efficacy Questionnaire (PSEQ)
3, 6, 9 and 12 months
Change from baseline in Fear-avoidance / kinesiophobia
Time Frame: 3, 6, 9 and 12 months
Tampa Scale of Kinesiophobia (TSK-17)
3, 6, 9 and 12 months
Change from baseline in Pain catastrophizing
Time Frame: 3, 6, 9 and 12 months
Pain Catastrophizing Scale (PCS)
3, 6, 9 and 12 months
Change from baseline in Psychosocial job aspects
Time Frame: 3, 6, 9 and 12 months
The Job Content Questionnaire (JCQ) is a tool for psychosocial job assessment.
3, 6, 9 and 12 months
Change from baseline in Lower Lumbar spine Kinematics
Time Frame: 3, 6, 9 and 12 months
Lower Lumbar kinematics of the spine were measured with the BodyGuard (sels-instruments nv). This is a remote measuring system.
3, 6, 9 and 12 months
Patient satisfaction of the intervention
Time Frame: 3, 6, 9 and 12 months
Patients' Global Impression of Change (PGIC) scale
3, 6, 9 and 12 months
Change from baseline in Category of risk of poor outcome (persistent disabling symptoms)
Time Frame: 3, 6, 9 and 12 months
The Start Back Screening Tool is used to screen primary care patients with low back pain for prognostic indicators that are relevant to initial decision making. The tool helps to group patients into 3 categories of risk of poor outcome (persistent disabling symptoms) - low, medium, and high-risk.
3, 6, 9 and 12 months
Change from baseline in Psychosocial aspects of work
Time Frame: 3, 6, 9 and 12 months
Psychosocial Aspects of Work Questionnaire (PAWQ)
3, 6, 9 and 12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Collaborators

Investigators

  • Principal Investigator: Wim Dankaerts, KU Leuven

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

December 1, 2012

Primary Completion (Actual)

May 1, 2014

Study Completion (Actual)

March 1, 2016

Study Registration Dates

First Submitted

June 12, 2013

First Submitted That Met QC Criteria

June 18, 2013

First Posted (Estimate)

June 20, 2013

Study Record Updates

Last Update Posted (Actual)

February 4, 2019

Last Update Submitted That Met QC Criteria

January 31, 2019

Last Verified

January 1, 2019

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Chronic Low Back Pain

Clinical Trials on Classification Based Cognitive Functional Therapy

Subscribe